You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia

Showing 1 - 25 of 5,361
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Chronic Lymphoid Malignancies Markers

Recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
    • Strasbourg, France
      Hematology Laboratory - Strasbourg University Hospitals
    Jul 2, 2021

    Grade 3a Follicular Lymphoma, Recurrent Burkitt Lymphoma, Recurrent DLBCL Trial in Atlanta, Columbus (other, drug, biological)

    Recruiting
    • Grade 3a Follicular Lymphoma
    • +14 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Atlanta, Georgia
    • +1 more
    May 31, 2022

    CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

    Recruiting
    • CLL/SLL
    • +8 more
    • Atlanta, Georgia
    • +3 more
    Feb 24, 2022

    Non Hodgkin Lymphoma, Follicular Lymphoma, Indolent Lymphoma Trial in Miami, Baltimore, Milwaukee (Zydelig)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • +8 more
    • Miami, Florida
    • +2 more
    Apr 21, 2022

    Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +8 more
    • Iopofosine I 131 single dose
    • +2 more
    • Redlands, California
    • +42 more
    Dec 30, 2022

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

    Completed
    • Multiple Myeloma
    • +7 more
    • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 2, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +23 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 23, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023

    B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

    Recruiting
    • B-Cell Lymphoma
    • +8 more
    • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
    • Pittsburgh, Pennsylvania
      AHN Cancer Institute - West Penn Hospital
    Aug 10, 2022

    Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

    Recruiting
    • Relapsed/Refractory B-cell Lymphomas
    • +11 more
    • CLBR001 and SWI019
    • Duarte, California
    • +7 more
    Jul 26, 2022

    Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma Trial in San Francisco (Fludarabine, Cyclophosphamide,

    Recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +8 more
    • San Francisco, California
      University of California, San Francisco
    May 2, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

    Active, not recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +22 more
    • Scottsdale, Arizona
    • +1 more
    Aug 10, 2021

    B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

    Active, not recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Anti-OX40 Antibody BMS 986178
    • +3 more
    • Palo Alto, California
      Stanford University, School of Medicine
    May 3, 2022

    Chronic Lymphocytic Leukemia, DLBCL, Follicular Lymphoma Trial in Duarte, Boston, Portland (Copanlisib, Nivolumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +2 more
    Mar 9, 2022

    Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

    Suspended
    • Lymphoplasmacytic Lymphoma
    • Waldenstrom Macroglobulinemia
    • Centralia, Illinois
    • +73 more
    Jul 27, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +20 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 11, 2022

    Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

    Completed
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    Sep 27, 2022

    Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

    Recruiting
    • Grade 1 Follicular Lymphoma
    • +7 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Dec 7, 2021

    Waldenstrom's Macroglobulinemia Trial in Italy (Bortezomib-Rituximab-Bendamustine)

    Completed
    • Waldenstrom's Macroglobulinemia
    • Messina, ME, Italy
    • +22 more
    Dec 1, 2020

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

    Active, not recruiting
    • Acute Biphenotypic Leukemia
    • +18 more
    • Aurora, Colorado
    • +2 more
    Dec 28, 2022

    Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)

    Terminated
    • Lymphoma, T-Cell, Cutaneous
    • +6 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jan 20, 2021

    Immune Responses to COVID-19 Vaccination in Lymphoma Patients

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • +12 more
      • Bedford, Bedfordshire, United Kingdom
      • +8 more
      Feb 22, 2022

      Chronic Lymphocytic Leukemia, Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Aichi, Miyagi, Tokyo (Idelalisib)

      Completed
      Has Results
      • Chronic Lymphocytic Leukemia
      • +5 more
      • Aichi, Japan
      • +2 more
      Feb 24, 2021